{"groups":[{"description":"Although the protocol initially had different disease intensities, ultimately, moved to one regimen for all patients.\n\nSubjects received 30mg/m\\^2 of Fludarabine from Day-7 until Day-3, 140mg/m\\^2 of Melphalan on Day-2, and 1.5mg/kg of Rabbit antithymocyte globulin at Day-7,-5,-3 and -1.\"","id":"FG000","title":"Treatment Group"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"87"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"87"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}